Michael was most recently Managing Partner of Optum Ventures, focused on digital health innovation. Previously, he was Co-Founder and CEO of Humedica, a pioneer and leader in the field of population health management and big data. Humedica was acquired by UnitedHealth Group (UHG) in 2013, and Michael broadened his role within UHG as President and CEO of Optum Analytics. Prior to launching Humedica, he served as Senior Managing Director at Leerink Partners, a leading healthcare investment bank. Michael also served as President and CEO of PHARMetrics, a health care informatics company, which was successfully sold to IMS Health in 2005. He serves as Founding Chairman of the Board of Phreesia, and is also Chairman of the Board of BroadReach, a global healthcare company headquartered in Cape Town, South Africa. He is an Entrepreneur in Residence at Harvard Business School focused on healthcare innovation, and a mentor and speaker at the Harvard Innovation Lab (iLab), a unique collaboration and education space designed to foster entrepreneurship. Michael is an advisor at the GLG Institute, a community of senior executives exchanging leadership and operational experience. He is an Advisory Board member of the Innovation and Digital Health Accelerator at Boston Children’s Hospital. Michael is a member of the Board of Directors of The College Diabetes Network (CDN), whose mission is to empower and improve the lives of students living with Type 1 diabetes through peer support and access to information and resources. He received his MBA from Harvard Business School and his bachelor’s degree in Economics from Brandeis University.